Approach
Precision Cardiac Drug Discovery
Cardiovascular disease remains the largest cause of mortality and healthcare costs, yet most therapies only focus on treating disease symptoms or lifestyle risk factors.
Precision cardiology is advancing genetically- and functionally-targeted therapies that can benefit patient heart function. But so far, there are very few well-characterized drug targets and therapies that have been validated in a functional human model.
Dynomics has developed a human-predictive discovery platform to power precision cardiac drug discovery.
